NCT06169514 Health Systems and Policy Contexts of Medical Oxygen
| NCT ID | NCT06169514 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Murdoch Childrens Research Institute |
| Condition | Hypoxemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1 participants |
| Start Date | 2024-07-31 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1 participants in total. It began in 2024-07-31 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a mixed-methods program evaluation from a health systems and policy perspective, involving (i) stakeholder analysis, (ii) policy-implementation gap analysis, and (iii) comparative country case studies. This study aims to understand how national oxygen strategies achieve impact at national, and subnational level, across country contexts, at what cost. The the investigators seek to: 1. Involve policymakers, implementers (including private sector), and medical oxygen users in identifying challenges and understanding potential solutions to medical oxygen access; 2. Generate new data on how medical oxygen systems work and can be improved from multiple perspectives; 3. Draw lessons on medical oxygen that can directly inform national and global practice and policy. This study will be conducted in 6 of the 9 countries participating in the Clinton Health Access Initiative (CHAI) led Medical Oxygen Implementation (MOXY) program (Uganda, Nigeria, Rwanda, Liberia, Lao PDR, Cambodia). Key informants will be selected representing government, non-governmental agencies, professional associations, private sector, and civil society. This study will be completed over 4 years, with timelines varying between country study sites.
Eligibility Criteria
Key informants will be selected representing government, non-governmental agencies, professional associations, private sector, and civil society.
Contact & Investigator
Hamish Graham, PhD
PRINCIPAL INVESTIGATOR
Murdoch Childrens Research Institute
Frequently Asked Questions
Who can join the NCT06169514 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypoxemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06169514 currently recruiting?
Yes, NCT06169514 is actively recruiting participants. Contact the research team at rami.subhi@mcri.edu.au for enrollment information.
Where is the NCT06169514 trial being conducted?
This trial is being conducted at Phnom Penh, Cambodia, Vientiane, Laos, Monrovia, Liberia, Ibadan, Nigeria and 2 additional locations.
Who is sponsoring the NCT06169514 clinical trial?
NCT06169514 is sponsored by Murdoch Childrens Research Institute. The principal investigator is Hamish Graham, PhD at Murdoch Childrens Research Institute. The trial plans to enroll 1 participants.